The antibody-based pharmaceuticals resource library’s Podcast
antibodybasedpharmaceuticalsresourcelibrary
3.0from 4 ratings
- 592
- Episodes
- 4
- Transcribed
- 4
- Ratings
- Monthly
- Cadence
- 2020
- First episode
About The antibody-based pharmaceuticals resource library’s Podcast
Podcasts for antibody-based pharmaceuticals including Therapeutic antibody/Antibody-drug conjugates/vaccine/CAR-T/Immunotherapy. Creative-Biolabs, the provider, is an outsourced research organization for antibody-drug development.
- Publisher
- antibodybasedpharmaceuticalsresourcelibrary
- Category
- education · science
- Language
- en
- Explicit
- No
- First episode
- 28 May 2020
- Latest episode
- 10 Sept 2026
Latest episodes
4 of 592 episodes have a transcript.
10 Sept 2026TRANSCRIPT
Webinar: Modeling T cell dysfunction in tumor microenvironments
16 Jun 2026TRANSCRIPT
The Future of Targeted Drug Delivery – Multimodal Imaging and Smart Nanocarriers
16 Jun 2026TRANSCRIPT
Sound Waves for Drug Delivery – Microbubbles, Sonoporation, and Photoacoustics
Inside a recent episode
Webinar: Modeling T cell dysfunction in tumor microenvironments
Published 10 Sept 2026 · Transcript excerpt
[…] I think we all can appreciate the T cells don't simply arrive on the scene and immediately start killing tumor cells. They spend a lot of time in the tumor tissue. And so we instead activated T cells in rich media and then passed them for varying amounts of time into the TIF media. And what was really interesting when we did this experiment was that the moment the T cells arrived in the TIF media, they stopped proliferating. you can see this here as as borne out they're expanding super super well in rpmi they enter into the tiff media and they flatline right now what's really intriguing is these t cells don't die it's just a cytostatic effect they sit there they still differentiate but they don't prolif they don't continue to proliferate what's more is the more time they spend in the tiff media the more dysfunctional they become so one day is enough to induce a little bit of dysfunction Three days and five days, all these cells are the same age. […]
Read the full transcript with a Pod Engine plan.
See plansReach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
- Apple Podcasts (US)
- 2.7 / 5
- 3 ratings
- Spotify
- 4.0 / 5
- 1 ratings
Contact The antibody-based pharmaceuticals resource library’s Podcast
- Guest appearances
- Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Questions about The antibody-based pharmaceuticals resource library’s Podcast
How often do new episodes come out?
The show publishes monthly, based on its RSS feed.
Does The antibody-based pharmaceuticals resource library’s Podcast take guests?
The show does not typically feature guests, based on episode analyses.
Where can I read transcripts?
4 of 592 episodes have a transcript on Pod Engine. Full transcripts are available with a Pod Engine plan.
Host of The antibody-based pharmaceuticals resource library’s Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine